Dept. of Oncology, Sahlgrenska University Hospital

Site:	Dept. of Oncology, Sahlgrenska University Hospital
Address:
City:	Gothenburg
State:
Zip:	SE-413 45
Country:	Sweden

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
2	Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)	Completed	Closed	Pazopanib (Votrient)	NCT01524848
3	Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST	Active, not recruiting	Closed	Imatinib	NCT02413736